Skip to content
Screener

QuidelOrtho Corporation QDEL Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

Abbott logo
AbbottABT
$486M+73.6%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$4.9M-37.2%
Danaher logo
DanaherDHR
$121M+0.8%
OraSure Technologies logo
OraSure TechnologiesOSUR
$445K
Labcorp Holdings logo
Labcorp HoldingsLH
$33M-14.5%
Haemonetics logo
HaemoneticsHAE
$3.62M-42.7%

Other financials

Income statement

See full
Revenue$630.9M+2.8%
Gross profit$272.9M-0.7%
Operating income-$21.8M+87.9%
Net income-$92.9M+63.6%
EPS (diluted)-$1.36+63.9%

Balance sheet

See full
Cash & equivalents$123.4M-18.7%
Total debt$3.4B+3.0%
Total equity$1.8B-36.4%
Total assets$5.7B-10.4%

Cash flow

See full
Operating cash flow-$110.6M
CapEx$25.5M-32.0%
Free cash flow-$136.1M-61.4%

Valuation

See full
Market cap$942.91M-41.3%
Enterprise value$4.25B-11.2%
P/S0.4×-0.2×

Profitability

See full
Gross margin44.6%-2.7pp
Operating margin-30.8%-49.9pp
Net margin-39.2%-168pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-45.9%-94.9pp
Debt / equity1.9×+0.7×
Current ratio1.4×+0.3×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The source filing: QuidelOrtho Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0001906324-26-000033
(In millions)June 28, 2026December 28, 2025
Accounts receivable$440.1$514.1
Allowance for contract rebates and discounts(72.9)(79.8)
Allowance for doubtful accounts(15.2)(17.3)
Total accounts receivable, net$352.0$417.0

Item 1. Financial Statements (unaudited)

FAQ

What is QuidelOrtho Corporation's allowance for doubtful accounts receivable (current)?
QuidelOrtho Corporation (QDEL) reported allowance for doubtful accounts receivable (current) of $15.2M in Q2 2026.
How has QuidelOrtho Corporation's allowance for doubtful accounts receivable (current) changed year-over-year?
QuidelOrtho Corporation's allowance for doubtful accounts receivable (current) decreased by 4.4% year-over-year, from $15.9M to $15.2M.
What is the long-term trend for QuidelOrtho Corporation's allowance for doubtful accounts receivable (current)?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's allowance for doubtful accounts receivable (current) has grown at a 8.9% compound annual growth rate (CAGR), from $14.6M to $17.3M.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about QuidelOrtho Corporation's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude